Neuberger Berman High Yield Strategies Fund Stock Price and Value Analysis
Should you buy Neuberger Berman High Yield Strategies Fund stock? (NYSE American:NHS). Let's see how it does in our automated value investing analysis system.
Advantages | Disadvantages |
---|---|
|
|
Inside the NHS Numbers
NHS Price (Neuberger Berman High Yield Strategies Fund stock price per share) |
$8.85 | |
[?]
|
PE Ratio versus Sector | 330% higher than other Financial stocks |
[?]
|
PE Ratio versus Industry | 226% higher than other Asset Management stocks |
[?]
|
Free Cash Flow Jitter | 0% |
[?]
|
Dividend Yield | 14% | Shares Shorted | 6,955 |
Is Neuberger Berman High Yield Strategies Fund Stock on Sale?
Based on our analysis, we believe that you should not buy Neuberger Berman High Yield Strategies Fund right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Should You Buy NHS Stock?
Does Neuberger Berman High Yield Strategies Fund have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.